Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Recurrent toxic epidermal necrolysis secondary to iopromide contrast.

Brown M, Yowler C, Brandt C.

J Burn Care Res. 2013 Jan-Feb;34(1):e53-6. doi: 10.1097/BCR.0b013e318257d88e.

PMID:
22929525
[PubMed - indexed for MEDLINE]
2.

Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.

La Grenade L, Lee L, Weaver J, Bonnel R, Karwoski C, Governale L, Brinker A.

Drug Saf. 2005;28(10):917-24.

PMID:
16180941
[PubMed - indexed for MEDLINE]
3.

Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.

Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schröder W, Roujeau JC; SCAR Study Group. Severe Cutaneous Adverse Reactions.

Arch Dermatol. 2002 Aug;138(8):1019-24.

PMID:
12164739
[PubMed - indexed for MEDLINE]
4.

Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.

Levi N, Bastuji-Garin S, Mockenhaupt M, Roujeau JC, Flahault A, Kelly JP, Martin E, Kaufman DW, Maison P.

Pediatrics. 2009 Feb;123(2):e297-304. doi: 10.1542/peds.2008-1923. Epub 2009 Jan 19.

PMID:
19153164
[PubMed - indexed for MEDLINE]
Free Article
5.

[Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].

Aberer W, Stingl G, Wolff K.

Hautarzt. 1982 Sep;33(9):484-90. German.

PMID:
7174320
[PubMed - indexed for MEDLINE]
6.

A case report and a proposed algorithm for the transfer of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis to a burn center.

Ellis MW, Oster CN, Turiansky GW, Blanchard JR.

Mil Med. 2002 Aug;167(8):701-4.

PMID:
12188246
[PubMed - indexed for MEDLINE]
7.

Fatal toxic epidermal necrolysis induced by carbamazepine treatment in a patient who previously had carbamazepine-induced Stevens-Johnson syndrome.

Huang LY, Liao WC, Chiou CC, Lou JP, Hu P, Ko FC.

J Formos Med Assoc. 2007 Dec;106(12):1032-7. doi: 10.1016/S0929-6646(08)60079-0. Review.

PMID:
18194909
[PubMed - indexed for MEDLINE]
8.

Toxic epidermal necrolysis after repeated injections of iohexol.

Rosado A, Canto G, Veleiro B, Rodríguez J.

AJR Am J Roentgenol. 2001 Jan;176(1):262-3. No abstract available.

PMID:
11133587
[PubMed - indexed for MEDLINE]
9.

Aetiology in sixteen cases of toxic epidermal necrolysis and Stevens-Johnson syndrome admitted within eight months in a teaching hospital.

Yeung CK, Ma SY, Hon C, Peiris M, Chan HH.

Acta Derm Venereol. 2003;83(3):179-82.

PMID:
12816151
[PubMed - indexed for MEDLINE]
10.

[Lyell syndrome or toxic epidermal necrolysis and Stevens-Johnson syndrome after treatment with fluoxetine].

Bodokh I, Lacour JP, Rosenthal E, Chichmanian RM, Perrin C, Vitetta A, Ortonne JP.

Therapie. 1992 Sep-Oct;47(5):441. French. No abstract available.

PMID:
1299992
[PubMed - indexed for MEDLINE]
11.

[Stevens-Johnson syndrome/toxic epidermal necrolysis].

Watanabe H.

Nihon Rinsho. 2012 Aug;70 Suppl 6:492-7. Japanese. No abstract available.

PMID:
23156557
[PubMed - indexed for MEDLINE]
12.

Management of ocular conditions in the burn unit: thermal and chemical burns and Stevens-Johnson syndrome/toxic epidermal necrolysis.

Lin A, Patel N, Yoo D, DeMartelaere S, Bouchard C.

J Burn Care Res. 2011 Sep-Oct;32(5):547-60. doi: 10.1097/BCR.0b013e31822b0f29. Review.

PMID:
21799437
[PubMed - indexed for MEDLINE]
13.

A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.

Arca E, Köse O, Erbil AH, Nişanci M, Akar A, Gür AR.

Pediatr Dermatol. 2005 Jul-Aug;22(4):317-20.

PMID:
16060867
[PubMed - indexed for MEDLINE]
14.

Stevens-Johnson syndrome and toxic epidermal necrolysis in a patient with systemic lupus erythematosus.

Burge SM, Dawber RP.

J Am Acad Dermatol. 1985 Oct;13(4):665-6. No abstract available.

PMID:
4078055
[PubMed - indexed for MEDLINE]
15.

Trimethoprim-sulfamethoxazole-induced Stevens-Johnson syndrome: a case report.

Langlois MR, Derk F, Belczyk R, Zgonis T.

J Am Podiatr Med Assoc. 2010 Jul-Aug;100(4):299-303.

PMID:
20660883
[PubMed - indexed for MEDLINE]
16.

Stevens-Johnson/toxic epidermal necrolysis overlap syndrome following lenalidomide treatment for multiple myeloma relapse after allogeneic transplantation.

Wäsch R, Jakob T, Technau K, Finke J, Engelhardt M.

Ann Hematol. 2012 Feb;91(2):287-9. doi: 10.1007/s00277-011-1235-y. Epub 2011 Apr 15. No abstract available.

PMID:
21494796
[PubMed - indexed for MEDLINE]
17.

[Management of cutaneous risk in pharmacovigilance: metabolic predisposition to Stevens-Johnson syndromes and toxic epidermal necrolysis].

Wolkenstein P.

Therapie. 1996 Sep-Oct;51(5):500-1. French. No abstract available.

PMID:
9138383
[PubMed - indexed for MEDLINE]
18.

Nevirapine-induced overlap stevens-johnson syndrome/toxic epidermal necrolysis.

Wetterwald E, Le Cleach L, Michel C, David F, Revuz J.

Br J Dermatol. 1999 May;140(5):980-2. No abstract available.

PMID:
10354056
[PubMed - indexed for MEDLINE]
19.

Stevens-Johnson syndrome and toxic epidermal necrolysis.

Marfatia YS.

Arch Dermatol. 1994 Aug;130(8):1073-4. No abstract available.

PMID:
8093181
[PubMed - indexed for MEDLINE]
20.

Stevens-Johnson Syndrome and toxic epidermal necrolysis: improving the support to victims.

Roujeau JC.

Drug Saf. 2013 Feb;36(2):145-6. doi: 10.1007/s40264-012-0008-4. No abstract available.

PMID:
23329542
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk